August 16, 2022
GENAC for the six months ended June 30, 2022, reported Gross premium written of $9.83 billion, 29% higher than the $7.64 billion reported for 2021. Reinsurance ceded rose 34% to close at $8.06 billion relative to $6.01 billion booked in 2021. Excess of loss reinsurance trended upwards by 26% to $130.35 million (2021: $103.06 million).
As a result, net premium written increased by 7% from $1.53 billion last year to $1.64 billion. Net premium written improved 9% within the second quarter to $758.25 million (2021: $695.46 million).
During the period under review Net changes in unearned premiums amounted to $23.45 million (2021: $69.37 million). Consequently, net premiums earned for the six months period grew by 11% to a total of $1.61 billion compared to $1.46 billion for the prior year. While net premiums earned for the quarter rose by 9% to a total of $803.76 million (2021: $737.86 million).
Commission income rose by 8%, year over year, from $465.57 million in 2021 to $504.72 million in 2022, while commission expenses increased by 4% from $270.71 million in 2021 to $281.45 million for the six months period.
Claims expenses saw a 25% increase, closing the six months period at $1.02 billion (2021: $811.59 million), while management expenses climbed by 21% to total $809.77 million compared to 2021’s total of $671.11 million.
Underwriting profit for the six months totalled of $7.97 million, this compares to an underwriting profit of $168.96 million booked in 2021. For the quarter, GENAC’s underwriting loss totaled $13.44 million in comparison to a profit of $142.67 million in 2021.
Investment income closed at $159.69 million, a 55% improvement when compared with last year’s corresponding total of $102.96 million, while other loss totalled $14.72 million for the period, relative to an income of $35.79 million in 2021. Other operating expenses grew by 13% to $83.74 million relative to $74.04 million in 2021.
Profit before taxation amounted to $66.17 million (2021: $230.97 million), down 71% year over year. Following taxes of $48.98 million (2021: $56.61 million). Net profit totalled $17.19 million for the period, a decline of 90% compared to the $174.37 million reported last year. Net loss for the quarter totaled $8.45 million, compared to the $158.84 million profit reported last year. Net profit attributable to shareholders amounted to $50.96 million (2021: $202.36 million). While net profit attributable to shareholders for the quarter closed at $1.97 million (2021: $166.30 million).
Total comprehensive income (TCI) year to date amounted to $21.42 million (2021: $232.94 million) for the period ended June 30, 2022. TCI for the quarter booked $21.25 million versus an income of $217.28 million in 2021.
As such, earning per share (EPS) for the period amounted to $0.05 (2021: $0.20) while EPS for the quarter amounted to $0.002 (2021: $0.16). The trailing twelve months EPS amounted to $0.10. The number of shares used in our calculations amounted to 1,031,250,000 units. The stock traded at $4.96 as at August 15, 2022 with a corresponding P/E of 49.49 times.
Balance Sheet at a glance:-
Total Assets increased by 11% to $12.73 billion as at June 30, 2022 from $11.47 billion a year earlier. The movement was mainly due to ‘Due from reinsurers and co-insurers’ which closed the period at $3.09 billion (2021: $2.30 billion).
Shareholder’s Equity as at June 30, 2022 stood at $2.68 billion (2021: $2.84 billion) resulting in book value per share of $2.60 (2021: $2.75).
Disclaimer:
Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
